Disclaimer & safety

PrecisePep exists to make peptide science legible. Every page on this site is assembled for education, literature navigation and research reference. It documents what has been reported — in trials, in mechanism papers, and in the uncontrolled grey market — so that a reader can tell those categories apart. It does not tell anyone what to do.

This is not medical advice. No content here establishes a clinician–patient relationship, diagnoses any condition, or recommends any treatment. It is not a substitute for a licensed physician, pharmacist, endocrinologist or veterinarian.

This is not an administration guide. Dosing ranges, reconstitution mathematics and protocol tables are reproduced so that published and community-reported figures can be studied, compared and critiqued. They are not instructions, and they are expressly not intended to assist any person in self-administering any compound.

Most compounds documented here are not approved for human use. Several are investigational drugs still in clinical development; several are research chemicals with no human approval anywhere; several are approved only for narrow indications under prescription. Purchasing, possessing or supplying them may be regulated or unlawful in your jurisdiction. Check your own law.

The grey market is unverified by definition. Research-grade material is not manufactured to pharmaceutical standard. Identity, purity, endotoxin load, peptide content and sterility vary between suppliers and between batches from the same supplier. Third-party analytical testing is the only meaningful check, and it is not a guarantee.

Evidence tiers are the point. Where this site labels something Study-Reported, that claim traces to published literature or a trial registry — often pre-clinical. Where it says Theorized, it is an inference from mechanism and has not been demonstrated. Where it says Grey Market & Community-Reported, it is uncontrolled self-report with no verification whatsoever. Those three things are not equivalent and this site will never present them as though they were.

No liability is accepted. Information is provided "as is", may contain errors, and may be out of date the moment a new trial reads out. Prime Edge Training, Brandon Mysliwiec and the authors of this site accept no liability for any decision made or action taken on the basis of anything published here. Verify everything against primary sources.

• Product quality. Research chemicals are not GMP-manufactured. Identity, purity, potency, endotoxin load and sterility vary by supplier and by batch.
• Pro-angiogenic and pro-proliferative signalling. Several compounds here promote new blood vessel growth, cell migration, or telomerase activity. These are the mechanisms and they are also the unresolved theoretical concern, particularly for anyone with an undiagnosed malignancy.
• Copper accumulation. Injected copper peptides bypass the intestinal regulation that normally controls copper absorption. This is measurable and is one of the few risks on this site that can be checked rather than guessed at.
• Glycaemic effects. Growth hormone secretagogues, glucagon-receptor agonists and AMPK activators all affect glucose handling — often in the same protocol, from different directions, with no monitoring.
• IGF-1 elevation. Sustained GH-axis stimulation raises IGF-1. Approved drugs in this class require IGF-1 monitoring by label for reasons that do not stop applying off-label.
• Drug interactions. Delayed gastric emptying alters oral drug absorption; GABAergic peptides interact with benzodiazepines; amylin analogues carry a boxed hypoglycaemia warning with insulin. None of this is characterised in multi-compound stacks.
• Anaphylaxis and hypersensitivity. Any injected substance can provoke an allergic reaction, and this is the risk on this list that acts fastest — typically within minutes. Widespread hives, swelling of the lips, tongue or throat, wheeze or difficulty breathing, vomiting or collapse means adrenaline into the outer thigh and an ambulance; antihistamines do not treat anaphylaxis. People with asthma, particularly poorly controlled asthma, are at markedly higher risk of a fatal outcome. Never inject anything for the first time alone. See injection harm, infection and anaphylaxis for the detail.
• Sterility and injection technique. Repeated self-injection of non-sterile-filled material carries infection risk independent of any pharmacology. Warning signs are spreading redness, swelling, heat, fever, or pain that worsens rather than settles after the first day or two.
• Anti-doping. Several compounds here are explicitly named on the WADA Prohibited List. Athletes subject to testing should verify against the current list rather than assume.

Talk to a physician. Not a coach, not a forum, not a vendor — a licensed clinician who can order and interpret bloodwork and who knows your history. Several of the risks documented across this site are measurable in a standard panel, and several of the compounds have contraindications that only a medical history would reveal.

Nothing on this site substitutes for that conversation, and nothing on this site is an encouragement to have it in order to obtain something specific.